EPC Dysfunction and Immune Networks: Translating Opportunities for Clinical Setting in Personalized Medicine
Publication date:
2018Publisher version:
http://dx.doi.org/10.2174/0929867324666170606101823Citación:
Current Medicinal Chemistry, 25(35), p. 4497-4506 (2018); doi:10.2174/0929867324666170606101823Descripción física:
p. 4497-4506Patrocinado por
The own research studies of the authors on EPC were funded by Fondo de Investigacion Sanitaria (FIS) [grant number PI12/00523 and PI16/00113] and partially by European FEDER funds. J. R-C. is supported by a postdoctoral contract from the "Juan de la Cierva" program from MINECO (Spain) [reference FJCI-2015-23849].
Id. Proyecto
FIS/FEDER/PI12/00523
FIS/FEDER/PI16/00113
MINECO/FJCI-2015-23849
Collections
- Artículos [27004]
